Access cutting-edge actinic keratoses treatment through this phase 1 clinical trial at a research site in Morgantown. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Morgantown location
Preparing your pre-screening questions…
Access actinic keratoses specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related actinic keratoses treatment provided free
Check if you qualify for this actinic keratoses clinical trial in Morgantown, WV
No-Cost Study Care
Local to Morgantown
Convenient for WV residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is looking at a new way to treat actinic keratoses, which are rough, scaly spots on the skin caused by long-term sun exposure. These spots are common in older adults and, if not treated, can sometimes develop into a type of skin cancer. Doctors often treat areas with many of these spots by using a prescription cream called 5-fluorouracil (5-FU), which helps remove damaged skin cells. This study is testing whether adding aluminum chloride hexahydrate, a medication commonly used to stop bleeding during skin procedures, can improve how well the cream works. People who take part in this study will receive one of two treatments applied to their skin: Standard treatment with 5% 5-fluorouracil cream, or A combination of 5% 5-fluorouracil cream plus 15% aluminum chloride hexahydrate cream The treatment will be applied for one week. A dermatologist will examine the treated skin areas, count the number of actinic keratoses, and take photographs before treatment begins, shortly after treatment ends, and again about eight weeks later. These visits help researchers compare how well each treatment reduces the number of skin spots over time. The goal of this study is to learn whether adding aluminum chloride hexahydrate to standard treatment helps reduce actinic keratoses more effectively than standard treatment alone.
Sponsor: West Virginia University
Yes, this clinical trial (NCT07401277) has an active research site in Morgantown, WV that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for actinic keratoses treatment options in Morgantown, WV, this clinical trial (NCT07401277) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Morgantown research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced actinic keratoses specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all actinic keratoses clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Morgantown — not just this study.
Browse Rheumatoid Arthritis Trials in Morgantown →